A detailed history of Invesco Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Invesco Ltd. holds 16,195,204 shares of BMY stock, worth $939 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
16,195,204
Previous 14,631,577 10.69%
Holding current value
$939 Million
Previous $608 Million 37.93%
% of portfolio
0.17%
Previous 0.13%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $62 Million - $80.9 Million
1,563,627 Added 10.69%
16,195,204 $838 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $89.5 Million - $118 Million
-2,223,481 Reduced 13.19%
14,631,577 $608 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $60.1 Million - $68.2 Million
1,253,027 Added 8.03%
16,855,058 $914 Million
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $220,874 - $263,564
-4,556 Reduced 0.03%
15,602,031 $801 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $71.8 Million - $80.3 Million
1,240,902 Added 8.64%
15,606,587 $906 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $23.6 Million - $26.2 Million
-369,668 Reduced 2.51%
14,365,685 $919 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $18.9 Million - $21.5 Million
-288,046 Reduced 1.92%
14,735,353 $1.02 Billion
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $255 Million - $302 Million
-3,723,858 Reduced 19.86%
15,023,399 $1.08 Billion
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $165,163 - $97.6 Million
1,270,485 Added 7.27%
18,747,257 $1.33 Billion
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $42 Million - $46.3 Million
578,586 Added 3.42%
17,476,772 $1.35 Billion
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $23.9 Million - $28.7 Million
-388,706 Reduced 2.25%
16,898,186 $1.23 Billion
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $83.4 Million - $97.3 Million
1,555,800 Added 9.89%
17,286,892 $1.08 Billion
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $19.6 Million - $23 Million
331,205 Added 2.15%
15,731,092 $931 Million
Q2 2021

Aug 17, 2021

SELL
$61.91 - $67.42 $99.6 Million - $108 Million
-1,608,299 Reduced 9.46%
15,399,887 $1.03 Billion
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $99.5 Million - $112 Million
-1,677,125 Reduced 8.98%
17,008,186 $1.07 Billion
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $146 Million - $165 Million
-2,522,611 Reduced 11.89%
18,685,311 $1.16 Billion
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $99.8 Million - $111 Million
-1,736,908 Reduced 7.57%
21,207,922 $1.28 Billion
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $17.8 Million - $20.8 Million
324,520 Added 1.43%
22,944,830 $1.35 Billion
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $123 Million - $178 Million
-2,642,278 Reduced 10.46%
22,620,310 $1.26 Billion
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $17.1 Million - $22.3 Million
346,940 Added 1.39%
25,262,588 $1.62 Billion
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $38.6 Million - $45.8 Million
902,962 Added 3.76%
24,915,648 $1.26 Billion
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $309 Million - $341 Million
6,915,526 Added 40.45%
24,012,686 $1.09 Billion
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $19.9 Million - $23.7 Million
440,868 Added 2.65%
17,097,160 $816 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $812 Million - $1.05 Billion
16,656,292 New
16,656,292 $866 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.